Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

28.91 -1.56 (-5.12%)
Official Closing Price Updated: 7:00 PM EST, Dec 1, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 103,624,045
Open 28.97
Bid (Size) 28.87 (1)
Ask (Size) 28.92 (20)
Prev. Close 30.47
Today's Range 28.30 - 29.40
52wk Range 28.30 - 54.93
Shares Outstanding 5,606,688,356
Dividend Yield 5.67%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Is Pfizer Stock a Buy Now?
Pfizer shares have fallen by double digits this year. 
Via The Motley Fool
Pfizer Tumbles After Abandoning Weight-Loss Pill
With shares already reflecting a post-COVID dearth of revenue streams, Pfizer's growth outlook recently took another hit as it halted development of its experimental weight-loss pill after a high rate... 
Via Talk Markets

Performance

YTD
-43.60%
-43.60%
1 Month
-5.21%
-5.21%
3 Month
-18.29%
-18.29%
6 Month
-25.20%
-25.20%
1 Year
-43.21%
-43.21%

More News

Read More
Why I'm Considering Selling Pfizer for Tax-Loss Harvesting Purposes
Via The Motley Fool
An Important History Lesson for Gene-Editing Investors
Via The Motley Fool
5 Top Stocks to Buy Before 2024
Via The Motley Fool
Stocks, Gold, Bonds Rally Further, Dollars Tumbles As Traders Anticipate Fed Cuts: What's Driving Markets Friday?
Via Benzinga
Topics Economy
Exposures Interest Rates
Why Is Hub Cyber Security (HUBC) Stock Up 30% Today?
Via InvestorPlace
Why Pfizer Stock Is Sinking Today
Via The Motley Fool
Why Is Altimmune (ALT) Stock Up 43% Today?
Via InvestorPlace
Pfizer Inc. (NYSE: PFE) is One of Friday Morning’s Most Active Stocks
Via Investor Brand Network
Pfizer Layoffs 2023: What to Know About the Latest PFE Job Cuts
Via InvestorPlace
Topics Workforce
Exposures Layoff
Texas Attorney General Alleges Pfizer Misled Public on COVID-19 Vaccine Efficacy
Via Benzinga
Topics Lawsuit
Exposures COVID-19 Financial Legal
How To Make $500 A Month With Pfizer Stock
Via Benzinga
Pfizer Halts Development Of Twice-Daily Weight-Loss Drug; PFE Stock Slides
Via Investor's Business Daily
Dow Jones Hits 2023 High, Nasdaq Slips; Tesla Cybertruck, Salesforce In Focus: Weekly Review
Via Investor's Business Daily
Topics Economy Stocks
Exposures Interest Rates US Equities
Pfizer’s Stock Is Down 44% YTD As Woes Continue
Via Talk Markets
Tale Of Two Investigational Obesity Drugs: Altimmune Stock Jumps, While Pfizer Trades Lower
Via Benzinga
This Twice Daily Weight Loss Drug Has Adverse Side Effects And Pfizer Wants To Discontinue It
Via Benzinga
Pfizer Announces Topline Phase 2b Results of Oral GLP-1R Agonist, Danuglipron, in Adults with Obesity
From Pfizer Inc.
Via Business Wire
Texas Sues Pfizer For "Misrepresenting COVID-19 Vaccine Efficacy" And "Conspiring To Censor Public Discourse"
Via Talk Markets
Topics Lawsuit
Exposures COVID-19 Financial Legal
ImmunoGen Stock Nearly Doubled On Thursday: What Happened?
Via Talk Markets
Billionaire Favorites: 3 Ultra-High Yield Stocks the Elite Love
Via InvestorPlace
Allergy Treatment Market Know Faster Growing Segments Now: Akorn, Pfizer, Novartis, Mylan N.V
Via SBWire
Anti-Inflammatory Drugs Market Boosting the Growth Worldwide 2030
Via SBWire
Loser Stocks: Buy More, Hold Or Sell?
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.